A review on the treatment of hyperlipidemia with Erchen Decoction
Hyperlipidemia, commonly referred to as dyslipidemia, is characterized by elevated serum cholesterol and/or triglyceride levels. This condition contributes significantly to the high mortality rates associated with cardiovascular diseases, posing a serious threat to global health. Although statins re...
Saved in:
| Main Authors: | Xinyang Tian, Peiyu Liu, Ruolin Wang, Yawei Hou, Ying Zhou, Chunyan Wang, Guiju Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1445950/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the mechanism of Erchen decoction in treating chronic bronchitis based on network pharmacology and molecular docking
by: Yanshan HE, et al.
Published: (2021-06-01) -
Prognostic role of lipoprotein(a) in atherosclerotic cardiovascular disease risk from a perspective on current risk stratification
by: Sha Li, et al.
Published: (2024-11-01) -
Prevalence of traditional cardiovascular risk factors in high-risk Kyrgyzstan population as compared to Indians − An Indo-Kyrgyz cardiometabolic study
by: Kamal Sharma, et al.
Published: (2024-12-01) -
Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018
by: Yan Jiang, et al.
Published: (2025-01-01) -
The efficacy and safety of Dachaihu decoction in the treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis
by: Zhiqing Mou, et al.
Published: (2024-07-01)